USANA Health Sciences Inc
NYSE:USNA
USANA Health Sciences Inc
NYSE:USNA
Price:
45.55 USD
-3.29%
Market Closed
Updated:
May 4, 2024
USANA Health Sciences Inc
Operating Income
|
USANA Health Sciences Inc
Operating Income Peer Comparison
Comparables:
EL
B
BRBR
COTY
IPAR
ELF
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
USANA Health Sciences Inc
NYSE:USNA
|
Operating Income
$90.9m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-2%
|
|
|
Estee Lauder Companies Inc
NYSE:EL
|
Operating Income
$1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-4%
|
|
B
|
Bellring Brands Inc
NYSE:BRBR
|
Operating Income
$285.1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Coty Inc
NYSE:COTY
|
Operating Income
$650.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
37%
|
CAGR 10-Years
4%
|
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Operating Income
$251.4m
|
CAGR 3-Years
53%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
|
|
elf Beauty Inc
NYSE:ELF
|
Operating Income
$140.6m
|
CAGR 3-Years
125%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
See Also
What is USANA Health Sciences Inc's Operating Income?
Operating Income
90.9m
USD
90.9m
USD
Based on the financial report for Mar 30, 2024, USANA Health Sciences Inc's Operating Income amounts to 90.9m USD.
What is USANA Health Sciences Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-2%
-2%
Over the last year, the Operating Income growth was -10%. The average annual Operating Income growth rates for USANA Health Sciences Inc have been -21% over the past three years , -13% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
